Rare Disease Revolution: How One-Time Gene Therapies are Changing Lives in 2025
For millions of people living with rare genetic disorders, 2025 represents a year of unprecedented hope. Historically, "orphan" diseases received little attention from big pharma due to small patient populations and high development costs. However, the modular nature of gene editing tools like CRISPR has changed the math. Once a delivery vehicle and a Cas-enzyme are validated for one disease,...
0 Commentarii 0 Distribuiri 70 Views 0 previzualizare